Timothy J. Sangiovanni, VP, Corporate Controller at KEMPHARM, INC (KMPH), bought 3,000 shares at $2.55 ($8K) on 2018-10-11, disclosed to the SEC on 2018-10-15.
Open-market purchase of $8k KMPH by VP, Corporate Controller. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 1,500 | $4K | 50.5% |
| 2 | $2.50 | 1,500 | $4K | 49.5% |
| Total | $2.52 avg | 3,000 | $8K | 100% |
| Filing → |
| ZVRA | SELL | 2025-02-14 | $24K | — | Filing → |
| ZVRA | BUY | 2023-03-13 | $5K | — | Filing → |
| KMPH | BUY | 2020-03-16 | $800 | — | Filing → |